CellCentric vs Lysoway Therapeutics
CellCentric vs Lysoway Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and Lysoway Therapeutics on 48/100.
Where each one leads
CellCentric
- our overall score: 60/100 against 48/100
- funding raised: $375M against $45.0M
- LinkedIn following: 28,695 against 1,282
Lysoway Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CellCentric | Lysoway Therapeutics |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. | Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2003 | 2021 |
| Headquarters | Cambridge, United Kingdom | Cambridge, USA |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CellCentric | Lysoway Therapeutics |
|---|---|---|
| Employees | 53 | Not published |
| Total funding | $375M | $45.0M |
| Latest round | Series D | Series A |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 28,695 | 1,282 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CellCentric | Lysoway Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 48/100 |
| Traction | 57/100 | 38/100 |
| Team | 60/100 | Not published |
| Community | Not published | 15/100 |
| Search visibility | 44/100 | 20/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | Not published |
| Domain ratingLink authority, 0-100 | 35/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CellCentric | Lysoway Therapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CellCentric vs Lysoway Therapeutics: common questions
Which is better, CellCentric or Lysoway Therapeutics?
On our 0-100 score CellCentric rates higher (60/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do CellCentric and Lysoway Therapeutics compare on the numbers?
CellCentric leads on our overall score (60/100 against 48/100), funding raised ($375M against $45.0M), LinkedIn following (28,695 against 1,282).
Read the full CellCentric review and pricing or the Lysoway Therapeutics review and pricing. You can also browse other CellCentric alternatives we track.